Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Tapentadol, a potent opioid, and carisoprodol, a muscle relaxant, pose significant health risks, including addiction and severe side effects such as respiratory collapse and confusion. The FDA's ...

India has banned the manufacture and export of two highly addictive opioids – tapentadol and carisoprodol after an expose found they were fuelling a public health crisis in parts of West Africa. India ...

This story also ran on CBS News. It can be republished for free. At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to ...

Feb. 25, 2025 – Planning surgery? Talking to your doctor about pain management beforehand could keep you off the path to long-term opioid use, a risk factor for addiction. If the operation is ...

Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

Purdue could take additional funds from the Sacklers' future sale of their other companies like Mundipharma, which sold opioids outside of the U.S. Those sales will happen outside of Purdue's ...

Accra, Feb 25, GNA – Mr Kwabena Mintah Akandoh, Minister of Health, Tuesday warned of a growing threat posed by illicit opioids in Ghana. In a statement to Parliament, on illegal opioids on the ...

At issue: whether opioid settlement money — paid by health care companies that were sued for fueling the opioid crisis and meant to help states abate addiction — should be funneled to two ...

The combination of tapentadol, a powerful opioid, and carisoprodol, an addictive muscle relaxant, is not approved for medical use due to its severe health risks, including breathing difficulties ...

RICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.

Two unregistered and highly-addictive opioids illegally imported into some West African countries from India, have been banned by the Indian Food and Drug Administration. Last week, a BBC Eye ...